Transplantation Conditioning
"Transplantation Conditioning" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Preparative treatment of transplant recipient with various conditioning regimens including radiation, immune sera, chemotherapy, and/or immunosuppressive agents, prior to transplantation. Transplantation conditioning is very common before bone marrow transplantation.
| Descriptor ID |
D019172
|
| MeSH Number(s) |
E02.095.465.425.450.800 E05.478.610.800
|
| Concept/Terms |
Transplantation Conditioning- Transplantation Conditioning
- Conditioning, Transplantation
- Conditionings, Transplantation
- Transplantation Conditionings
|
Below are MeSH descriptors whose meaning is more general than "Transplantation Conditioning".
Below are MeSH descriptors whose meaning is more specific than "Transplantation Conditioning".
This graph shows the total number of publications written about "Transplantation Conditioning" by people in this website by year, and whether "Transplantation Conditioning" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 2 | 2 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 3 | 2 | 5 |
| 2003 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 2 | 3 | 5 |
| 2006 | 1 | 2 | 3 |
| 2007 | 0 | 3 | 3 |
| 2008 | 7 | 3 | 10 |
| 2009 | 3 | 4 | 7 |
| 2010 | 2 | 3 | 5 |
| 2011 | 1 | 4 | 5 |
| 2012 | 1 | 6 | 7 |
| 2013 | 7 | 1 | 8 |
| 2014 | 10 | 2 | 12 |
| 2015 | 11 | 4 | 15 |
| 2016 | 4 | 2 | 6 |
| 2017 | 8 | 9 | 17 |
| 2018 | 15 | 6 | 21 |
| 2019 | 9 | 5 | 14 |
| 2020 | 5 | 18 | 23 |
| 2021 | 4 | 3 | 7 |
| 2022 | 0 | 8 | 8 |
| 2023 | 0 | 4 | 4 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transplantation Conditioning" by people in Profiles.
-
How I treat blastic plasmacytoid dendritic cell neoplasm. Blood. 2025 Feb 06; 145(6):567-576.
-
Outcomes of Standard-Risk Multiple Myeloma Patients Who Undergo Upfront Autologous Hematopoietic Stem Cell Transplantation. Transplant Cell Ther. 2025 Mar; 31(3):166.e1-166.e9.
-
Transplant in ALL: who, when, and how? Hematology Am Soc Hematol Educ Program. 2024 12 06; 2024(1):93-101.
-
Haploidentical vs HLA-matched sibling donor HCT with PTCy prophylaxis: HLA factors and donor age considerations. Blood Adv. 2024 10 22; 8(20):5306-5314.
-
Association of busulfan exposure and outcomes after HCT for patients with an inborn error of immunity. Blood Adv. 2024 10 08; 8(19):5137-5145.
-
High activity of the new myeloablative regimen of gemcitabine/clofarabine/busulfan for allogeneic transplant for aggressive lymphomas. Bone Marrow Transplant. 2024 Dec; 59(12):1754-1762.
-
Donor types and outcomes of transplantation in myelofibrosis: a?CIBMTR study. Blood Adv. 2024 08 27; 8(16):4281-4293.
-
Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trial. J Hematol Oncol. 2024 06 27; 17(1):50.
-
Chidamide combined with a modified Bu-Cy conditioning regimen improves survival in patients with T-cell acute lymphoblastic leukemia/lymphoma undergoing allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2024 Aug; 103(8):3083-3093.
-
Future directions in haploidentical hematopoietic stem cell transplantation. Hematology. 2024 Dec; 29(1):2366718.